v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
9 Months Ended
Jan. 31, 2025
Jan. 31, 2024
Cash flows from operating activities:    
Net income $ 185,938 $ 106,949
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 59,756 58,075
Stock-based compensation expense 33,464 30,260
Provision for doubtful accounts 12,918 17,204
Gain on marketable securities (27,992) (22,801)
Deferred income taxes 5,964 (18,818)
Gain on cash surrender value of life insurance policies (7,253) (6,444)
Impairment of right-of-use assets 2,452 1,629
Impairment of fixed assets 509 1,575
Change in other assets and liabilities:    
Accounts payable and accrued liabilities (127,755) (147,559)
Receivables due from clients (35,933) (37,320)
Deferred compensation 39,860 49,609
Unearned compensation (13,803) (4,274)
Income taxes and other receivables (13,347) (8,712)
Income taxes payable (7,364) 3,410
Prepaid expenses and other assets 4,279 (158)
Other (3,144) (520)
Net cash provided by operating activities 108,549 22,105
Cash flows from investing activities:    
Cash paid for acquisitions, net of cash acquired (44,442) 0
Purchase of property and equipment (42,191) (43,287)
Proceeds from sales/maturities of marketable securities 33,428 38,138
Purchase of marketable securities (31,916) (40,714)
Premium on company-owned life insurance policies (28,213) (14,953)
Proceeds from life insurance policies 612 16,272
Dividends received from unconsolidated subsidiaries 40 0
Net cash used in investing activities (112,682) (44,544)
Cash flows from financing activities:    
Repurchases of common stock (73,920) (30,128)
Dividends paid to shareholders (58,576) (36,906)
Payments of tax withholdings on restricted stock (17,053) (10,609)
Proceeds from issuance of common stock in connection with an employee stock purchase plan 7,868 8,347
Dividends - noncontrolling interest (3,038) (4,496)
Principal payments on finance leases (1,211) (1,361)
Payments on life insurance policy loans (519) (123)
Net cash used in financing activities (146,449) (75,276)
Effect of exchange rate changes on cash and cash equivalents (11,125) (9,512)
Net decrease in cash and cash equivalents (161,707) (107,227)
Cash and cash equivalents at beginning of period 941,005 844,024
Cash and cash equivalents at end of the period $ 779,298 $ 736,797

Source